Mettler-Toledo International Inc. (NYSE:MTD) Stock Position Cut by Bamco Inc. NY

Bamco Inc. NY trimmed its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.0% during the third quarter, Holdings Channel reports. The institutional investor owned 288,747 shares of the medical instruments supplier’s stock after selling 5,857 shares during the period. Mettler-Toledo International makes up about 1.2% of Bamco Inc. NY’s holdings, making the stock its 17th largest position. Bamco Inc. NY’s holdings in Mettler-Toledo International were worth $433,034,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MTD. Edgestream Partners L.P. increased its stake in shares of Mettler-Toledo International by 1,270.6% during the third quarter. Edgestream Partners L.P. now owns 3,262 shares of the medical instruments supplier’s stock valued at $4,892,000 after acquiring an additional 3,024 shares during the period. Eventide Asset Management LLC boosted its stake in Mettler-Toledo International by 7.5% during the 3rd quarter. Eventide Asset Management LLC now owns 79,129 shares of the medical instruments supplier’s stock valued at $118,670,000 after purchasing an additional 5,504 shares in the last quarter. Atlantic Union Bankshares Corp increased its position in shares of Mettler-Toledo International by 13.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 2,073 shares of the medical instruments supplier’s stock valued at $3,109,000 after purchasing an additional 244 shares during the period. Capstone Investment Advisors LLC raised its stake in shares of Mettler-Toledo International by 4.4% in the 3rd quarter. Capstone Investment Advisors LLC now owns 517 shares of the medical instruments supplier’s stock worth $775,000 after buying an additional 22 shares in the last quarter. Finally, Vinva Investment Management Ltd boosted its stake in Mettler-Toledo International by 74.2% during the third quarter. Vinva Investment Management Ltd now owns 2,364 shares of the medical instruments supplier’s stock valued at $3,496,000 after buying an additional 1,007 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Stock Up 0.6 %

Shares of NYSE:MTD opened at $1,251.20 on Monday. The company’s fifty day moving average is $1,345.17 and its two-hundred day moving average is $1,392.37. The company has a market cap of $26.40 billion, a P/E ratio of 33.73, a price-to-earnings-growth ratio of 4.13 and a beta of 1.16. Mettler-Toledo International Inc. has a 12-month low of $1,068.33 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Equities research analysts anticipate that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.94% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Stifel Nicolaus cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Wells Fargo & Company dropped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Robert W. Baird decreased their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. JPMorgan Chase & Co. increased their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Finally, Evercore ISI lifted their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $1,338.75.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.